Growth Metrics

Travere Therapeutics (TVTX) Long-Term Investments (2018 - 2019)

Travere Therapeutics (TVTX) has disclosed Long-Term Investments for 3 consecutive years, with $15.0 million as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Long-Term Investments changed 0.0% year-over-year to $15.0 million, compared with a TTM value of $15.0 million through Jun 2019, changed 0.0%, and an annual FY2018 reading of $15.0 million, changed N/A over the prior year.
  • Long-Term Investments was $15.0 million for Q2 2019 at Travere Therapeutics, roughly flat from $15.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $15.0 million in Q1 2018 and bottomed at $15.0 million in Q1 2018.